A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

NCT02627027 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Duvie Tab. 0.5mg, Glucodaun OR Tab. 750mg
DRUG: CKD-395 0.25/750mg

Sponsor

Chong Kun Dang Pharmaceutical